文献速递头颈部肿瘤放疗放疗物理与技术

SEAFARER头颈研究:PSQA设备的敏感性与特异性取决于使用方式而非设备本身

It's not your device, it's how you use it - Sensitivity and specificity of PSQA devices in the SEAFARER head and neck study.
PubMed 文献 · Radiother Oncol · 2026-03-20

全设备总体敏感性79%、特异性82%,但48%(21/44)的中心至少通过了一个「应失败」计划;5种常用PSQA设备敏感性范围0-100%,每种设备均有至少一次达到100%敏感性与100%特异性。结论认为中心间PSQA系统性能差异大,常用设备性能由用户选择而非设备固有特性决定。

要点

  • 全设备总体敏感性79%、特异性82%,但各中心间差异很大。
  • 5种常用PSQA设备敏感性范围0-100%,每种设备均至少有一次100%敏感性和100%特异性。

核心结论

  • PSQA系统的敏感性和特异性在各中心之间差异很大。
  • 常用PSQA设备的性能由用户选择而非设备固有特性决定。

研究设计与样本

  • 采用商业剂量模拟算法,基于既定计划为常见直线加速器模型创建质量和稳健性相似的计划。

主要发现

  • 48%(21/44)的中心用其临床PSQA系统至少通过了一个「应失败」计划。
  • 所有设备的总体敏感性为79%,特异性为82%。
  • 多个中心报告审查或更改了其PSQA方案。
  • 5种常用PSQA设备(用于5份以上提交)纳入比较,敏感性范围为0-100%。
  • 每种常用设备均至少有一次达到100%敏感性和100%特异性的完美评分。

关键数值与推荐

  • 误差计划按剂量学影响分为「应通过」或「应失败」两类。
  • 常用PSQA设备指用于5份以上提交的设备。
  • 全设备总体敏感性79%、特异性82%。
  • 5种常用设备敏感性范围0-100%,每种设备均至少有一次100%敏感性和100%特异性。

临床怎么用

  • 中心可用SEAFARER方法学评估本中心PSQA系统检测故意引入误差的能力并与社区结果比较。
  • 应关注PSQA使用流程与用户选择对误差检测能力的影响,而非仅更换设备。
  • 参与本研究的多个中心在结果反馈后审查或更改了PSQA方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is large variability in patient specific quality assurance (PSQA) devices, techniques and protocols used clinically in radiotherapy. The SEAFARER methodology enables centres to evaluate their PSQA system's ability to detect intentionally introduced errors and compare their findings with community results. AIM: This study assessed the performance of PSQA systems in detecting simulated delivery errors for a head and neck radiotherapy case. METHODS: A commercial dose-mimicking algorithm was employed to create plans of similar quality and robustness for common linac models based on an established plan. Using Python scripting, eleven copies of these plans were created and modified to simulate different delivery errors which were classified based on their dosimetric impact as 'should-pass' or 'should-fail'. Participating centres were asked to use their clinical PSQA methodologies to determine which of the modified plans passed their PSQA processes when compared to the unmodified plan's dose prediction. RESULTS: Eighty-nine submissions were received from 44 centres. Using their clinical PSQA systems, 48% (21/44) of centres passed at least one 'should-fail' plan. Overall sensitivity and specificity across all devices were 79% and 82%, respectively. Multiple centres reported a review or change of their PSQA protocol. Five common PSQA devices (used for 5+ submissions) were included in a comparison. Sensitivities ranged 0-100%, with every common device having at least one perfect score of 100% sensitivity and 100% specificity. CONCLUSION: Sensitivity and specificity of PSQA systems varied greatly between centres. User choices rather than inherent characteristics determine the performance of common PSQA devices.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. May L, Baeza-Ortega JA, Hussein M, et al. It's not your device, it's how you use it - Sensitivity and specificity of PSQA devices in the SEAFARER head and neck study. Radiother Oncol. 2026. PMID: 41865996. doi:10.1016/j.radonc.2026.111493

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。